Palmon is short for “Pal monsters”—nothing digital or pocket-sized about it! This fully original title revolves around collecting various monsters and pitting them against their peers. Plus, the ...

After working with Blake Lively on the Another Simple Favor films, Lionsgate has acquired the Tom Melia spec The Survival List as a starring vehicle for the actress that she’ll also produce, Deadline ...

What if one of history’s most devastating disasters wasn’t actually natural? This deep dive explores the shocking truth behind a catastrophe that was planned. Tesla said it didn’t have key data in a ...

A 2:1 aspect ratio crop of Witchspire cover artwork. Envar has now taken to the 2025 edition of Gamescom to unveil its first original IP, Witchspire. Described as a co-op survival adventure, the title ...

The catastrophic crash of an Air India Dreamliner flight in June killed 241 passengers and crew members. However, the tragedy also told a remarkable story of survival—a lone passenger who defied ...

This week at Gamescom, Keen Games revealed that Enshrouded's next big update would finally get players wet, with a whole new biome dedicated to water. And while I was expecting a few rivers and ponds, ...

Most studies on how exercise affects the survival of people with cancer have been observational. A clinical trial provides compelling evidence of the benefits of physical activity. Doris S. M. Chan is ...

More than two years after the FDA held a public workshop on measuring overall survival (OS) in clinical cancer trials, the agency has released a draft guidance on the topic, recommending that OS be ...

As much as games have changed since the original PlayStation, a handful of the era’s titles did so much to define their genres that it’s impossible to escape their influence today. Silent Hill and ...

A 90-day pause on additional tariffs on China offers no relief to American companies already facing extraordinarily high import taxes imposed by President Trump. Holly Eve may have to close Madame ...

In the heat of the CDK4/6 market showdown, Eli Lilly has notched an overall survival win to back Verzenio’s case against Novartis’ rival offering. Lilly’s Verzenio has proven its ability to prolong ...